Table 1 |
||||
|
Sensitivity analysis |
||||
|
PCI Day 0-1 |
PCI Day 2-29 |
|||
|
Landmark analyses |
Log rank |
P-value |
Log rank |
P-value |
|
|
||||
|
Day 91-180 |
||||
|
Death |
0.11 |
0.002 |
||
|
Recurrent MI |
0.17 |
0.07 |
||
|
Combined |
0.06 |
0.007 |
||
|
Day 181-540 |
||||
|
Death |
0.25 |
0.001 |
||
|
Recurrent MI |
0.33 |
0.99 |
||
|
Combined |
0.65 |
0.1 |
||
|
Cox Proportional Hazards Model |
HR (CI)* |
P-value |
HR (CI)* |
P-value |
|
|
||||
|
Day 91-180 |
||||
|
Death |
||||
|
No clopidogrel |
1.00 |
1.00 |
||
|
Clopidogrel |
0.49 (0.23-0.97) |
0.04 |
0.28 (0.12-0.64) |
0.003 |
|
Recurrent MI |
||||
|
No clopidogrel |
1.00 |
1.00 |
||
|
Clopidogrel |
0.71 (0.42-1.19) |
0.19 |
0.75 (0.40-1.38) |
0.35 |
|
Combined |
||||
|
No clopidogrel |
1.00 |
1.00 |
||
|
Clopidogrel |
0.66 (0.43-1.02) |
0.06 |
0.62 (0.37-1.04) |
0.07 |
|
Day 181-540 |
||||
|
Death |
||||
|
No clopidogrel |
1.00 |
1.00 |
||
|
Clopidogrel |
0.83 (0.55-1.23) |
0.34 |
0.55 (0.35-0.86) |
0.01 |
|
Recurrent MI |
||||
|
No clopidogrel |
1.00 |
1.00 |
||
|
Clopidogrel |
1.17 (0.76-1.81) |
0.48 |
0.79 (0.50-1.24) |
0.3 |
|
Combined |
||||
|
No clopidogrel |
1.00 |
1.00 |
||
|
Clopidogrel |
0.92 (0.68-1.25) |
0.58 |
0.73 (0.53-1.02) |
0.07 |
|
|
||||
|
* Hazard ratio (confidence intervals). |
||||
|
Sørensen et al. BMC Cardiovascular Disorders 2010 10:6 doi:10.1186/1471-2261-10-6 |
||||
